Hematopoietic Cell Freezing Medium
Hematopoietic Cell Freezing Medium: Serum-free freezing medium optimized for Peripheral Blood Mononuclear Cells (PBMC)
Size: 50 ml
Price: $90.00
Description
Hematopoietic Cell Freezing Medium is an optimized formulation intended to support the cryopreservation of human hematopoietic cells, Peripheral Blood Mononuclear Cells (PBMC), including CD34-positive hematopoietic stem and progenitor cells (HSPC), bone-marrow mononuclear cells, and cord-blood-derived cell populations. When used with an appropriate freezing, storage, and thawing protocol, cryopreservation media help reduce cellular injury associated with ice formation, osmotic stress, cryoprotectant exposure, and temperature changes during the freeze–thaw process. Post-thaw recovery and function depend on the cell source, cell concentration, cryoprotectant composition, cooling rate, storage conditions, thawing procedure, and downstream culture conditions.
Hematopoietic stem and progenitor cells are found primarily in specialized bone-marrow microenvironments after birth. During fetal development, hematopoiesis occurs in several tissues, including the fetal liver, and hematopoietic cells are also present in umbilical cord blood. HSPCs can be detected in peripheral blood and may be collected in larger numbers after mobilization. These cells contribute to the lifelong production and replenishment of the blood and immune systems through self-renewal and differentiation into multiple hematopoietic lineages, including erythroid cells, megakaryocytes and platelets, myeloid cells, and lymphoid cells.
In research and translational workflows, cryopreservation facilitates sample transport, batch processing, biobanking, and experimental scheduling. Hematopoietic Cell Freezing Medium is intended to help maintain cell recovery and viability after thawing when used according to the recommended protocol. Depending on the cell type and application, post-thaw evaluation may include cell recovery, viability, CD34 expression, subset composition, colony-forming activity, proliferation, engraftment-related assays, or other functional endpoints. Researchers should validate the post-thaw characteristics relevant to their specific application rather than relying on viability alone.
The medium supports research involving hematopoietic stem and progenitor-cell biology, bone-marrow and cord-blood models, immunology, gene-editing workflows, cell and gene therapy development, and regenerative-medicine research.
